Grufity logo
Grufity logo

Latest Saturn V Capital Management LLC Stock Portfolio

$552Million | No. of Holdings #21

Saturn V Capital Management LLC Performance

2026 Q1+8.66%
YTD+8.66%
2025+79.96%

About Saturn V Capital Management LLC and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Saturn V Capital Management LP reported an equity portfolio of $552.2 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Saturn V Capital Management LP are , AMLX, . The fund has invested 12.8% of it's portfolio in ALUMIS INC and 10.9% of portfolio in AMYLYX PHARMACEUTICALS INC. <br><br> The fund managers got completely rid off OCULAR THERAPEUTIX INC (OCUL), CENTESSA PHARMACEUTICALS PLC (CNTA) and INVENTIVA SA (IVA) stocks. They significantly reduced their stock positions in COGENT BIOSCIENCES INC (COGT), DYNE THERAPEUTICS INC (DYN) and JAZZ PHARMACEUTICALS PLC (JAZZ). Saturn V Capital Management LP opened new stock positions in CANDEL THERAPEUTICS INC (CADL) and ZURA BIO LTD. The fund showed a lot of confidence in some stocks as they added substantially to OVID THERAPEUTICS INC (OVID), DISC MEDICINE INC and INVIVYD INC (ADGI).
Saturn V Capital Management LLC Equity Portfolio Value
Last Reported on: 15 May, 2026
$552Million
  as of May 15, 2026

Saturn V Capital Management LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Saturn V Capital Management LP made a return of 8.66% in the last quarter. In trailing 12 months, it's portfolio return was 133.49%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
candel therapeutics inc14,193,300
zura bio ltd4,402,760
alto neuroscience inc2,000,700
satellos bioscience inc1,970,500
New stocks bought by Saturn V Capital Management LLC

Additions

Ticker% Inc.
ovid therapeutics inc66.67
disc medicine inc50.76
invivyd inc41.55
immix biopharma inc23.15
x4 pharmaceuticals inc11.31
monopar therapeutics inc6.12
pharvaris n v5.38
vaxcyte inc3.2
Additions to existing portfolio by Saturn V Capital Management LLC

Reductions

Ticker% Reduced
cogent biosciences inc-48.51
dyne therapeutics inc-45.96
jazz pharmaceuticals plc-34.31
abivax sa-16.4
celcuity inc-11.1
amylyx pharmaceuticals inc-3.26
Saturn V Capital Management LLC reduced stake in above stock

Sold off

Ticker$ Sold
ocular therapeutix inc-18,269,200
inventiva sa-1,316,720
centessa pharmaceuticals plc-7,070,130
Saturn V Capital Management LLC got rid off the above stocks

Sector Distribution

Saturn V Capital Management LP has about 58.3% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare58.3
Others39.1
2.6

Market Cap. Distribution

Saturn V Capital Management LP has about 5.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • MID-CAP
  • SMALL-CAP
  • MICRO-CAP
  • LARGE-CAP
Category%
UNALLOCATED39.1
MID-CAP22
SMALL-CAP19.5
MICRO-CAP13.8
LARGE-CAP5.6

Stocks belong to which Index?

About 39.5% of the stocks held by Saturn V Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others60.5
RUSSELL 200039.5
Top 5 Winners (%)%
alumis inc
122.8 %
IMMX
immix biopharma inc
62.8 %
oculis holding ag
33.1 %
OVID
ovid therapeutics inc
27.0 %
PCVX
vaxcyte inc
25.4 %
Top 5 Winners ($)$
alumis inc
38.9 M
IMMX
immix biopharma inc
13.0 M
PCVX
vaxcyte inc
9.7 M
AMLX
amylyx pharmaceuticals inc
8.1 M
CELC
celcuity inc
4.3 M
Top 5 Losers (%)%
ADGI
invivyd inc
-43.4 %
IKT
inhibikase therapeutics inc
-18.0 %
disc medicine inc
-16.8 %
abivax sa
-16.0 %
MNPR
monopar therapeutics inc
-15.7 %
Top 5 Losers ($)$
abivax sa
-14.0 M
ADGI
invivyd inc
-10.9 M
disc medicine inc
-5.8 M
MNPR
monopar therapeutics inc
-3.5 M
DYN
dyne therapeutics inc
-2.0 M

Saturn V Capital Management LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Saturn V Capital Management LLC

Saturn V Capital Management LP has 21 stocks in it's portfolio. About 77% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Saturn V Capital Management LP last quarter.

$552.22MTotal Value
24.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Saturn V Capital Management LLC, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
IVA
Inventiva Sa

Inventiva Sa

IVA
Saturn V Capital Management LLC's holding in Inventiva Sa over time
0%0.00
$0.00
0%
decreased 100 percentsold off
PHVS
Pharvaris N V

Pharvaris N V

PHVS
Saturn V Capital Management LLC's holding in Pharvaris N V over time
6.15%1,201,400
$33.94M
6.15%
increased 5.38 percentadded
Com
Alumis Inc

Alumis Inc

Saturn V Capital Management LLC's holding in Alumis Inc over time
12.77%3,202,080
$70.54M
12.77%
increased 2.11 percentadded
Sponsored Ads
Abivax Sa

Abivax Sa

Saturn V Capital Management LLC's holding in Abivax Sa over time
10.94%542,696
$60.43M
10.94%
decreased 16.4 percentreduced
Com
Disc Medicine Inc

Disc Medicine Inc

Saturn V Capital Management LLC's holding in Disc Medicine Inc over time
5.21%449,926
$28.77M
5.21%
increased 50.76 percentadded